Immunology
3 drugs are in development for Autoimmune Diseases.
- Companies
- 3
- Clinical trials
- 22
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Autoimmune Diseases pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 1(3)
| Drug | Company |
|---|---|
| anito-cel | Arcellx, Inc. (ACLX) |
| m230 | MOMENTA PHARMACEUTICALS INC (MNTA) |
| rlyb116 | Rallybio Corp (RLYB) |
About this indication
Autoimmune Diseases context
Immunology·MeSH: Autoimmune Diseases (D001327)
Also known as: Disease, Autoimmune
Frequently asked questions
How many drugs are in development for Autoimmune Diseases?
BioSniper tracks 3 drugs in development for Autoimmune Diseases across 3 companies.
How many clinical trials target Autoimmune Diseases?
There are 22 clinical trials targeting Autoimmune Diseases tracked by BioSniper.